Durect CORP Form 4 insider transactions

DURECT Corp's Chief Medical Officer, Norman Sussman, reports the sale of 9,000 common stock shares due to an inadvertent administrative error.
DURECT Corporation's CEO, James E. Brown, reported a gift of 56,000 common stock shares and updated his beneficial ownership.
DURECT Corporation's CFO, Timothy M. Papp, acquired 275,000 shares of common stock through a restricted stock unit award.